文献速递脑血管病

1型与2型糖尿病患者缺血性与出血性卒中风险:瑞典全国队列研究

Risk of Ischemic and Hemorrhagic Stroke in Individuals With Type 1 and Type 2 Diabetes: A Nationwide Cohort Study in Sweden.
PubMed 文献 · Neurology · 2025-03-13

该瑞典全国队列研究纳入2005至2019年国家糖尿病登记中47,720例1型糖尿病和686,158例2型糖尿病患者,并按年龄和性别匹配无糖尿病对照。1型糖尿病患者缺血性卒中风险为对照的2.54倍,出血性卒中风险为1.88倍;2型糖尿病患者缺血性卒中风险为1.37倍,出血性卒中风险无显著增加。

要点

  • 1型糖尿病患者缺血性卒中风险为对照的2.54倍,出血性卒中风险为1.88倍。
  • 2型糖尿病患者缺血性卒中风险为对照的1.37倍,出血性卒中风险无显著增加。
  • 1型糖尿病出血性卒中风险自HbA1c>52 mmol/mol起显著升高,2型糖尿病仅在HbA1c>72 mmol/mol时小幅升高。

核心结论

  • 1型和2型糖尿病患者的缺血性卒中风险均高于无糖尿病对照。
  • 1型糖尿病患者出血性卒中风险也高于无糖尿病对照,而2型糖尿病仅在HbA1c>72 mmol/mol时与出血性卒中风险显著相关。
  • 作者认为这些发现突显了糖尿病中卒中风险增加,且按卒中亚型和糖尿病类型呈现不同模式,作者提出针对性预防策略至关重要。

研究设计与样本

  • 基于瑞典国家糖尿病登记2005至2019年的全国队列研究,纳入1型或2型糖尿病患者,并按年龄和性别匹配无糖尿病对照。
  • 纳入1型糖尿病47,720例(平均年龄34.4岁,女性44.8%)和2型糖尿病686,158例(平均年龄65.3岁,女性43.3%),分别匹配143,160例和2,058,474例对照。
  • 从多个国家登记处收集基线特征、合并症、用药和结局数据,使用Cox比例风险模型按糖尿病类型分层估计卒中亚型的发病率比和校正风险比。

主要发现

  • 1型糖尿病患者缺血性卒中风险为对照的2.54倍(95%CI 2.36-2.73),出血性卒中风险为对照的1.88倍(95%CI 1.57-2.26)。
  • 2型糖尿病患者缺血性卒中风险为对照的1.37倍(95%CI 1.35-1.38),出血性卒中风险无显著增加(HR 0.99,95%CI 0.96-1.02)。
  • 两种糖尿病类型中,较高的HbA1c水平均与缺血性卒中风险增加相关。
  • 1型糖尿病患者出血性卒中风险自HbA1c>52 mmol/mol起显著升高,2型糖尿病患者仅在HbA1c>72 mmol/mol时观察到小幅风险增加。

关键数值与推荐

  • 1型糖尿病:缺血性卒中风险为对照的2.54倍(95%CI 2.36-2.73),出血性卒中风险为对照的1.88倍(95%CI 1.57-2.26)。
  • 2型糖尿病:缺血性卒中风险为对照的1.37倍(95%CI 1.35-1.38),出血性卒中HR 0.99(95%CI 0.96-1.02)。
  • 1型糖尿病出血性卒中风险自HbA1c>52 mmol/mol起显著升高;2型糖尿病仅在HbA1c>72 mmol/mol时观察到小幅风险增加。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Diabetes significantly increases the risk of cardiovascular events, including stroke. Although the association with ischemic stroke is well established, the relationship with hemorrhagic stroke remains unclear. This study aimed to evaluate the risk of ischemic and hemorrhagic stroke in individuals with type 1 and type 2 diabetes compared with diabetes-free controls from the general population. METHODS: This cohort study included individuals with type 1 or type 2 diabetes from the Swedish National Diabetes Register between 2005 and 2019, matched to diabetes-free controls by age and sex. Data on baseline characteristics, comorbidities, medications, and outcomes were collected from multiple national registers. Stroke incidence rates and adjusted hazard ratios were estimated using Cox proportional hazard models, stratified by diabetes type, for ischemic and hemorrhagic stroke. RESULTS: The study included 47,720 individuals with type 1 diabetes (mean age 34.4, 44.8% female) and 686,158 with type 2 diabetes (mean age 65.3, 43.3% female), matched to 143,160 and 2,058,474 controls, respectively. In individuals with type 1 diabetes, the ischemic stroke risk was 2.54 times higher (95% CI 2.36-2.73) and the hemorrhagic stroke risk was 1.88 times higher (95% CI 1.57-2.26) compared with controls. In individuals with type 2 diabetes, the ischemic stroke risk was 1.37 times higher (95% CI 1.35-1.38) while the hemorrhagic stroke risk was not significantly increased (HR: 0.99, 95% CI 0.96-1.02). Higher HbA1c levels were associated with increased ischemic stroke risk for both diabetes types. For hemorrhagic stroke, individuals with type 1 diabetes had significantly higher risk starting at HbA1c > 52 mmol/mol while in those with type 2 diabetes, a modest risk increase was observed only at HbA1c > 72 mmol/mol. DISCUSSION: The risk of ischemic stroke was higher for both diabetes types. Individuals with type 1 diabetes also exhibited a higher risk of hemorrhagic stroke compared with diabetes-free controls while type 2 diabetes was significantly associated with risk of hemorrhagic stroke only when HbA1c was higher than 72 mmol/mol. These findings highlight the increased stroke risk in diabetes, with distinct patterns by stroke subtype and diabetes type. Tailored prevention strategies are essential to address these differences.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Mavridis A, Viktorisson A, Eliasson B, et al. Risk of Ischemic and Hemorrhagic Stroke in Individuals With Type 1 and Type 2 Diabetes: A Nationwide Cohort Study in Sweden. Neurology. 2025. PMID: 40080734. doi:10.1212/WNL.0000000000213480

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。